Enterobacter infections are commonly found in nosocomial settings and Enterobacter spp. have been recognized as increasingly important pathogens. They are intrinsically resistant to aminopenicillins, cefazolin, and cefoxitin because they produce constitutive chromosome AmpC beta-lactamase. Enterobacter spp. are recovered from the respiratory tract, surgical wounds, urinary tract, and blood and are implicated in a broad range of clinical syndromes.
Category
Bacterial infectious disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
01 Certain infectious or parasitic diseases
Gastroenteritis or colitis of infectious origin
Bacterial foodborne intoxications
1A1Y Other specified bacterial foodborne intoxications
H00300 Enterobacter infection
Genome-based classification of infectious diseases [BR:br08401]
Bacterial infections
Infections caused by enterobacteria
H00300 Enterobacter infection
Approximately 31% of Enterobacter spp. infections in intensive care units in the United States involve strains not susceptible to third-generation cephalosporins.
